Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

10.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

3.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

9.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.8K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

9.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Prenatal iodine supplementation and early childhood neurodevelopment: the PoppiE trial - study protocol for a multicentre randomised controlled trial.

BMJ open·2023
Same author

Corrigendum to "Feline mammary carcinoma stem cells are tumorigenic, radioresistant, chemoresistant and defective in activation of the ATM/p53 DNA damage pathway" [The Veterinary Journal 196 (2013) 414-423].

Veterinary journal (London, England : 1997)·2021
Same author

Simultaneous measurement of p53:Mdm2 and p53:Mdm4 protein-protein interactions in whole cells using fluorescence labelled foci.

Scientific reports·2019
Same author

Standard terminology for reproductive tissue and cell products for use in ART.

Human reproduction open·2019
Same author

Synthetic 10FN3-based mono- and bivalent inhibitors of MDM2/X function.

Protein engineering, design & selection : PEDS·2018
Same author

Enhancing Specific Disruption of Intracellular Protein Complexes by Hydrocarbon Stapled Peptides Using Lipid Based Delivery.

Scientific reports·2017

Video Experimental Relacionado

Updated: Mar 13, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

300

Pequeños péptidos activan la función de unión al ADN específica de la secuencia latente de p53

T R Hupp1, A Sparks, D P Lane

  • 1Department of Biochemistry, Dundee University, Scotland.

Cell
|October 20, 1995
PubMed
Resumen

Las células normales activan la proteína p53 para la transcripción a través de la radiación UV o la intervención de anticuerpos. Este estudio introduce un sistema de activación peptídica, revelando la regulación alostérica de p53 y allanando el camino para nuevos modificadores de la respuesta p53.

Más Videos Relacionados

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K
High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
06:38

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy

Published on: February 7, 2019

9.3K

Videos de Experimentos Relacionados

Last Updated: Mar 13, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

300
Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K
High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
06:38

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy

Published on: February 7, 2019

9.3K

Área de la Ciencia:

  • Biología Molecular Biología Molecular
  • La bioquímica es la bioquímica.
  • Regulación de las comunicaciones celulares.

Sus antecedentes:

  • La proteína p53 normalmente está latente en las células, pero puede ser activada para la transcripción específica de la secuencia por radiación UV.
  • La activación ocurre sin un aumento en los niveles de proteína p53, lo que sugiere que la modificación post-traducional es clave.

Objetivo del estudio:

  • Para investigar el mecanismo de activación de la p53.
  • Desarrollar un sistema específico de activación de péptidos para p53.3.
  • Para explorar la regulación alostérica frente a la estérica de la actividad de p53.

Principales métodos:

  • Microinyección de células con anticuerpos dirigidos al dominio regulador negativo C-terminal de p53.
  • Utilizando pequeños péptidos derivados del dominio regulador negativo de p53.
  • Desarrollo de un sistema de activación de péptidos.

Principales resultados:

  • La microinyección de anticuerpos activó la función p53 sin daños por rayos UV, lo que indica que la modificación post-traducional in vivo es limitante de la tasa.
  • Los péptidos se utilizaron para diferenciar entre los mecanismos de regulación negativa alostéricos y estéricos.
  • Se desarrolló un sistema específico de activación de péptidos consistente con la regulación alostérica.

Conclusiones:

  • La modificación postraslacional del dominio regulador negativo de la p53 es un paso crítico que limita la velocidad de activación de la p53.
  • El sistema peptídico desarrollado apoya un mecanismo alostérico para la regulación negativa de p53.
  • Este trabajo establece un precedente para la creación de nuevos modificadores de moléculas pequeñas de la respuesta p53.